These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19285059)

  • 41. Sphingolipids as bioactive regulators of thrombin generation.
    Deguchi H; Yegneswaran S; Griffin JH
    J Biol Chem; 2004 Mar; 279(13):12036-42. PubMed ID: 14722105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
    Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
    Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes.
    Nguyen VH; Kassiou M; Johnston GA; Christie MJ
    Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.
    Maier CA; Wünsch B
    J Med Chem; 2002 Jan; 45(2):438-48. PubMed ID: 11784148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling.
    Maceyka M; Milstien S; Spiegel S
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S272-6. PubMed ID: 18987387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The oligomeric states of the purified sigma-1 receptor are stabilized by ligands.
    Gromek KA; Suchy FP; Meddaugh HR; Wrobel RL; LaPointe LM; Chu UB; Primm JG; Ruoho AE; Senes A; Fox BG
    J Biol Chem; 2014 Jul; 289(29):20333-44. PubMed ID: 24847081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ
    Thum S; Schepmann D; Ayet E; Pujol M; Nieto FR; Ametamey SM; Wünsch B
    Eur J Med Chem; 2019 Sep; 177():47-62. PubMed ID: 31129453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.
    Laggner C; Schieferer C; Fiechtner B; Poles G; Hoffmann RD; Glossmann H; Langer T; Moebius FF
    J Med Chem; 2005 Jul; 48(15):4754-64. PubMed ID: 16033255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent.
    Chen YY; Wang X; Zhang JM; Deuther-Conrad W; Zhang XJ; Huang Y; Li Y; Ye JJ; Cui MC; Steinbach J; Brust P; Liu BL; Jia HM
    Bioorg Med Chem; 2014 Oct; 22(19):5270-8. PubMed ID: 25189691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Substituted 1-phenyl-2-cyclopropylmethylamines with high affinity and selectivity for sigma sites.
    Ronsisvalle G; Marrazzo A; Prezzavento O; Pasquinucci L; Falcucci B; Di Toro RD; Spampinato S
    Bioorg Med Chem; 2000 Jun; 8(6):1503-13. PubMed ID: 10896126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sphingosine-1-phosphate metabolism: A structural perspective.
    Pulkoski-Gross MJ; Donaldson JC; Obeid LM
    Crit Rev Biochem Mol Biol; 2015; 50(4):298-313. PubMed ID: 25923252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists.
    Izenwasser S; Thompson-Montgomery D; Deben SE; Chowdhury IN; Werling LL
    Eur J Pharmacol; 1998 Apr; 346(2-3):189-96. PubMed ID: 9652359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacophore identification for sigma-1 (sigma1) receptor binding: application of the "deconstruction-reconstruction-elaboration" approach.
    Glennon RA
    Mini Rev Med Chem; 2005 Oct; 5(10):927-40. PubMed ID: 16250835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting.
    Cuvillier O; Ader I; Bouquerel P; Brizuela L; Malavaud B; Mazerolles C; Rischmann P
    Curr Mol Pharmacol; 2010 Jun; 3(2):53-65. PubMed ID: 20302564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of σ Receptor Ligands with a Spirocyclic System Connected with a Tetrahydroisoquinoline Moiety via Different Linkers.
    Bergkemper M; Schepmann D; Wünsch B
    ChemMedChem; 2021 Apr; 16(7):1184-1197. PubMed ID: 33332704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular cloning and pharmacological characterization of the rat sigma1 receptor.
    Mei J; Pasternak GW
    Biochem Pharmacol; 2001 Aug; 62(3):349-55. PubMed ID: 11434908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ
    Kopp N; Civenni G; Marson D; Laurini E; Pricl S; Catapano CV; Humpf HU; Almansa C; Nieto FR; Schepmann D; Wünsch B
    Eur J Med Chem; 2021 Jul; 219():113443. PubMed ID: 33901806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of high-fat diet on the sphingolipid pathway of signal transduction in regenerating rat liver.
    Zabielski P; Baranowski M; Błachnio-Zabielska A; Zendzian-Piotrowska M; Górski J
    Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):75-83. PubMed ID: 20599517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
    Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
    J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medicinal Chemistry of σ
    Weber F; Wünsch B
    Handb Exp Pharmacol; 2017; 244():51-79. PubMed ID: 28620761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.